Osteopontin: Role in extracellular matrix deposition and myocardial remodeling post-MI

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 3, 2010, Pages 538-543

  Singh, Mahipal ^a   Foster, Cerrone R ^a   Dalal, Suman ^a   Singh, Krishna ^a  

^a East Tennessee State University   (United States)

Author keywords

ECM; MMPs; Myocardial infarction; Myocardial remodeling; Osteopontin

Indexed keywords

MATRIX METALLOPROTEINASE; OSTEOPONTIN;

BIOLOGICAL ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EXTRACELLULAR MATRIX; GENE ACTIVATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; EXTRACELLULAR MATRIX; HUMANS; MICE; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; MYOCARDIUM; OSTEOPONTIN;

MUS;

EID: 77649275745     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.06.015     Document Type: Review

References (50)

1. Opie L.H., Commerford P.J., Gersh B.J., Pfeffer M.A. Controversies in ventricular remodelling. Lancet 2006, 367:356-367.
2. Frangogiannis N.G. The mechanistic basis of infarct healing. Antioxid. Redox Signal. 2006, 8:1907-1939.
3. Janicki J.S., Brower G.L. The role of myocardial fibrillar collagen in ventricular remodeling and function. J. Card. Fail. 2002, 8:S319-S325.
4. Lindsey M.L., Mann D.L., Entman M.L., Spinale F.G. Extracellular matrix remodeling following myocardial injury. Ann. Med. 2003, 35:316-326.
5. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 2007, 87:1285-1342.
6. Schellings M.W., Pinto Y.M., Heymans S. Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc. Res. 2004, 64:24-31.
7. Sangaletti S., Colombo M.P. Matricellular proteins at the crossroad of inflammation and cancer. Cancer Lett. 2008, 267:245-253.
8. Kazanecki C.C., Uzwiak D.J., Denhardt D.T. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J. Cell. Biochem. 2007, 102:912-924.
9. Uede T., Katagiri Y., Iizuka J., Murakami M. Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein?. Microbiol. Immunol. 1997, 41:641-648.
10. Singh M., Ananthula S., Milhorn D.M., Krishnaswamy G., Singh K. Osteopontin: a novel inflammatory mediator of cardiovascular disease. Front. Biosci. 2007, 12:214-221.
11. Wang K.X., Denhardt D.T. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 2008, 19:333-345.
12. Scatena M., Liaw L., Giachelli C.M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2302-2309.
13. O'Regan A. The role of osteopontin in lung disease. Cytokine Growth Factor Rev. 2003, 14:479-488.
14. Singh K., Balligand J.L., Fischer T.A., Smith T.W., Kelly R.A. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase. J. Biol. Chem. 1995, 270:28471-28478.
15. Trueblood N.A., Xie Z., Communal C., Sam F., Ngoy S., Liaw L., et al. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ. Res. 2001, 88:1080-1087.
16. Williams E.B., Halpert I., Wickline S., Davison G., Parks W.C., Rottman J.N. Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters. Circulation 1995, 92:705-709.
17. Graf K., Do Y.S., Ashizawa N., Meehan W.P., Giachelli C.M., Marboe C.C., et al. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 1997, 96:3063-3071.
18. Singh K., Sirokman G., Communal C., Robinson K.G., Conrad C.H., Brooks W.W., et al. Myocardial osteopontin expression coincides with the development of heart failure. Hypertension 1999, 33:663-670.
19. Sam F., Xie Z., Ooi H., Kerstetter D.L., Colucci W.S., Singh M., et al. Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. Am. J. Hypertens. 2004, 17:188-193.
20. Subramanian V., Krishnamurthy P., Singh K., Singh M. Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H673-H683.
21. Szalay G., Sauter M., Haberland M., Zuegel U., Steinmeyer A., Kandolf R., et al. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ. Res. 2009, 104:851-859.
22. Murry C.E., Giachelli C.M., Schwartz S.M., Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am. J. Pathol. 1994, 145:1450-1462.
23. Xie Z., Singh M., Singh K. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice. Hypertension 2004, 44:826-831.
24. Stawowy P., Blaschke F., Pfautsch P., Goetze S., Lippek F., Wollert-Wulf B., et al. Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur. J. Heart Fail. 2002, 4:139-146.
25. Satoh M., Nakamura M., Akatsu T., Shimoda Y., Segawa I., Hiramori K. Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy. Eur. J. Heart Fail. 2005, 7:755-762.
26. Suezawa C., Kusachi S., Murakami T., Toeda K., Hirohata S., Nakamura K., et al. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function. J. Lab. Clin. Med. 2005, 145:33-40.
27. Tamura A., Shingai M., Aso N., Hazuku T., Nasu M. Osteopontin is released from the heart into the coronary circulation in patients with a previous anterior wall myocardial infarction. Circ. J. 2003, 67:742-744.
28. Xie Z., Singh M., Singh K. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J. Cell. Physiol. 2004, 198:399-407.
29. Liaw L., Almeida M., Hart C.E., Schwartz S.M., Giachelli C.M. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ. Res. 1994, 74:214-224.
30. Xie Z., Pimental D.R., Lohan S., Vasertriger A., Pligavko C., Colucci W.S., et al. Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species. J. Cell. Physiol. 2001, 188:132-138.
31. Zhang Y.L., Zhou S.X., Lei J., Yuan G.Y., Wang J.F. Blockades of angiotensin and aldosterone reduce osteopontin expression and interstitial fibrosis infiltration in rats with myocardial infarction. Chin. Med. J. (Engl.) 2008, 121:2192-2196.
32. Krishnamurthy P., Peterson J.T., Subramanian V., Singh M., Singh K. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction. Mol. Cell. Biochem. 2009, 322:53-62.
33. Hayakawa Y., Chandra M., Miao W., Shirani J., Brown J.H., Dorn G.W., et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 2003, 108:3036-3041.
34. Olivetti G., Capasso J.M., Sonnenblick E.H., Anversa P. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ. Res. 1990, 67:23-34.
35. Matsui Y., Jia N., Okamoto H., Kon S., Onozuka H., Akino M., et al. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 2004, 43:1195-1201.
36. Xie Z., Singh M., Siwik D.A., Joyner W.L., Singh K. Osteopontin inhibits interleukin-1beta-stimulated increases in matrix metalloproteinase activity in adult rat cardiac fibroblasts: role of protein kinase C-zeta. J. Biol. Chem. 2003, 278:48546-48552.
37. Ono K., Matsumori A., Shioi T., Furukawa Y., Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 1998, 98:149-156.
38. Kaludercic N., Lindsey M.L., Tavazzi B., Lazzarino G., Paolocci N. Inhibiting metalloproteases with PD 166793 in heart failure: impact on cardiac remodeling and beyond. Cardiovasc. Ther. 2008, 26:24-37.
39. Mujumdar V.S., Smiley L.M., Tyagi S.C. Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Int. J. Cardiol. 2001, 79:277-286.
40. Wang G.Y., Bergman M.R., Nguyen A.P., Turcato S., Swigart P.M., Rodrigo M.C., et al. Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility. Cardiovasc. Res. 2006, 69:688-696.
41. Hayashidani S., Tsutsui H., Ikeuchi M., Shiomi T., Matsusaka H., Kubota T., et al. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1229-H1235.
42. Mukherjee B.B., Nemir M., Beninati S., Cordella-Miele E., Singh K., Chackalaparampil I., et al. Interaction of osteopontin with fibronectin and other extracellular matrix molecules. Ann. N. Y. Acad. Sci. 1995, 760:201-212.
43. Kaartinen M.T., Pirhonen A., Linnala-Kankkunen A., Maenpaa P.H. Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties. J. Biol. Chem. 1999, 274:1729-1735.
44. Ashizawa N., Graf K., Do Y.S., Nunohiro T., Giachelli C.M., Meehan W.P., et al. Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J. Clin. Invest. 1996, 98:2218-2227.
45. Collins A.R., Schnee J., Wang W., Kim S., Fishbein M.C., Bruemmer D., et al. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. J. Am. Coll. Cardiol. 2004, 43:1698-1705.
46. Lenga Y., Koh A., Perera A.S., McCulloch C.A., Sodek J., Zohar R. Osteopontin expression is required for myofibroblast differentiation. Circ. Res. 2008, 102:319-327.
47. Agnihotri R., Crawford H.C., Haro H., Matrisian L.M., Havrda M.C., Liaw L. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J. Biol. Chem. 2001, 276:28261-28267.
48. Zahradka P. Novel role for osteopontin in cardiac fibrosis. Circ. Res. 2008, 102:270-272.
49. Liaw L., Skinner M.P., Raines E.W., Ross R., Cheresh D.A., Schwartz S.M., et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J. Clin. Invest. 1995, 95:713-724.
50. Zhao X., Johnson J.N., Singh K., Singh M. Impairment of myocardial angiogenic response in the absence of osteopontin. Microcirculation 2007, 14:233-240.